Key facts
- This page summarizes Peter R. Chase's Form 4 filing for CHASE CORP.
- 8 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Nov 2023, 19:20.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Disposed to Issuer
Disposed to Issuer
Disposed to Issuer
Disposed to Issuer
Disposed to Issuer
Disposed to Issuer
Disposed to Issuer
Disposed to Issuer
Additional SEC filing notes
Section 16 status
Peter R. Chase is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger, dated as of July 21, 2023, by and among Chase Corporation (the "Issuer"), Formulations Parent Corporation ("Parent") and Formulations Merger Sub Corporation, a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub", pursuant to which, effective as of November 15, 2023 (the "Effective Time"), Merger Sub merged with and into the Issuer, with the Issuer surviving the merger as a wholly owned subsidiary of Parent (the "Merger") and each issued and outstanding share of the Issuer's Common Stock (each, a "Share") was cancelled and converted into the right to receive $127.50 in cash (the "Per Share Consideration"), subject to any applicable withholding of taxes and without interest.
Footnote F2
Represents shares held by the Peter R. Chase Insurance Trust.
Footnote F3
Represents shares held by the Peter R. Chase Insurance Trust - GST Exempt.
Footnote F4
Represents shares held by the Chase 2015 Irrevocable Trust.
Footnote F5
Represents shares held by the Peter R. Chase Trust.
Footnote F6
Represents shares held by the Peter R. Chase 2022 Qualified Annuity Trust #1.
Footnote F7
Represents shares held by the Peter R. Chase 2022 Qualified Annuity Trust #2.
Footnote F8
Represents shares held by the Peter R. Chase 2022 Qualified Annuity Trust #3.